Geng An Feng - Net Worth and Insider Trading
Geng An Feng Net Worth
The estimated net worth of Geng An Feng is at least $5 Million dollars as of 2025-07-24. Geng An Feng is the senior management of Cabio Biotech (Wuhan) Co Ltd and owns about 165,746 shares of Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) stock worth over $5 Million. Details can be seen in Geng An Feng's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Geng An Feng has not made any transactions after 2024-02-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Geng An Feng
Geng An Feng Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Geng An Feng owns 1 companies in total, including Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) .
Click here to see the complete history of Geng An Feng’s form 4 insider trades.
Insider Ownership Summary of Geng An Feng
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
SHSE:688089 | Cabio Biotech (Wuhan) Co Ltd | 2024-02-06 | senior management |
Geng An Feng Latest Holdings Summary
Geng An Feng currently owns a total of 1 stock. Geng An Feng owns 165,746 shares of Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) as of February 6, 2024, with a value of $5 Million.
Latest Holdings of Geng An Feng
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SHSE:688089 | Cabio Biotech (Wuhan) Co Ltd | 2024-02-06 | 165,746 | 27.40 | 4,541,440 |
Holding Weightings of Geng An Feng
Geng An Feng Form 4 Trading Tracker
According to the SEC Form 4 filings, Geng An Feng has made a total of 11 transactions in Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) over the past 5 years, including 7 buys and 3 sells. The most-recent trade in Cabio Biotech (Wuhan) Co Ltd is the acquisition of 9,400 shares on February 6, 2024, which cost Geng An Feng around $99,161.
Insider Trading History of Geng An Feng
- 1
Geng An Feng Trading Performance
GuruFocus tracks the stock performance after each of Geng An Feng's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Geng An Feng is 7.31%. GuruFocus also compares Geng An Feng's trading performance to market benchmark return within the same time period. The performance of stocks bought by Geng An Feng within 3 months outperforms 2 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Geng An Feng's insider trading performs compared to the benchmark.
Performance of Geng An Feng
Geng An Feng Ownership Network
Ownership Network List of Geng An Feng
Ownership Network Relation of Geng An Feng

Geng An Feng Owned Company Details
What does Cabio Biotech (Wuhan) Co Ltd do?
Who are the key executives at Cabio Biotech (Wuhan) Co Ltd?
Geng An Feng is the senior management of Cabio Biotech (Wuhan) Co Ltd. Other key executives at Cabio Biotech (Wuhan) Co Ltd include Core technical personnel Shang Yun , senior management Xiao Min , and Directors & senior managers Wang Hua Biao .
Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) Insider Trades Summary
Over the past 18 months, Geng An Feng made 2 insider transaction in Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) with a net purchase of 20,136. Other recent insider transactions involving Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) include a net sale of 24,080 shares made by Shang Yun , a net sale of 25,800 shares made by Xiao Min , and a net purchase of 20,000 shares made by Du Bin .
In summary, during the past 3 months, insiders sold 22,080 shares of Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) in total and bought 0 shares, with a net sale of 22,080 shares. During the past 18 months, 53,880 shares of Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) were sold and 63,108 shares were bought by its insiders, resulting in a net purchase of 9,228 shares.
Cabio Biotech (Wuhan) Co Ltd (SHSE:688089)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cabio Biotech (Wuhan) Co Ltd Insider Transactions
Geng An Feng Mailing Address
Above is the net worth, insider trading, and ownership report for Geng An Feng. Currently GuruFocus does not have mailing address information for Geng An Feng.